KalVista Pharmaceuticals Files 8-K Report
Ticker: KALV · Form: 8-K · Filed: Jul 7, 2025 · CIK: 1348911
| Field | Detail |
|---|---|
| Company | Kalvista Pharmaceuticals, Inc. (KALV) |
| Form Type | 8-K |
| Filed Date | Jul 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory
TL;DR
KalVista dropped an 8-K, check for new info.
AI Summary
On July 7, 2025, KalVista Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD disclosure. No specific financial figures or material events beyond the filing itself were detailed in the provided text.
Why It Matters
This filing indicates KalVista Pharmaceuticals is providing updated information to the SEC, which could include material disclosures relevant to investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific material events or financial data that would indicate a change in risk.
Key Numbers
- 001-36830 — SEC File Number (Identifies the company's filing with the SEC.)
- 20-0915291 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- KalVista Pharmaceuticals, Inc. (company) — Registrant
- Carbylan Therapeutics, Inc. (company) — Former Company Name
- Carbylan Biosurgery, Inc (company) — Former Company Name
- 001-36830 (dollar_amount) — SEC File Number
- 20-0915291 (dollar_amount) — IRS Employer Identification No.
FAQ
What specific 'Other Events' are disclosed in this 8-K filing?
The provided text does not specify the details of the 'Other Events' beyond listing it as an item in the filing.
Are there any new financial statements or exhibits attached to this filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the content of these documents is not detailed in the provided text.
Does the Regulation FD Disclosure pertain to any recent material non-public information?
The provided text mentions 'Regulation FD Disclosure' as an item but does not specify the content or any information disclosed.
What was the previous name of KalVista Pharmaceuticals, Inc.?
KalVista Pharmaceuticals, Inc. was formerly known as Carbylan Therapeutics, Inc. and Carbylan Biosurgery, Inc.
When was the name change from Carbylan Therapeutics, Inc. to KalVista Pharmaceuticals, Inc.?
The name change from Carbylan Therapeutics, Inc. occurred on September 16, 2014.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 7, 2025 regarding KalVista Pharmaceuticals, Inc. (KALV).